The document discusses standing orders, which are written orders signed by a licensed practitioner that allow nurses to provide specific care for symptoms or clinical problems without a new direct order. Examples of situations where standing orders may be used include administration of immunizations, treatment of common health issues, screening activities, and orders for lab tests. The document also provides several examples of specific standing orders related to obstetric care, postpartum care, and newborn care.
With having many challenges surrounding the nurse midwives in India, she still delivers good obstetrician care and can bringing good health of mother and child. can decrease ratio of LSCS. looking for many established centers/clinics/hospitals/birthing centers which runs by midwives independently in India
Preparation for delivery of mother, baby and midwife and equipmentsDR MUKESH SAH
In addition to their delivery bags, midwives “carry” many other invaluable tools ... family planning, delivery preparation, postnatal counseling and breastfeeding. ... With this equipment, we can recover 80% of newborns. ... “Midwifery feels good when both the mother and baby come out of the labor ward alive.
With having many challenges surrounding the nurse midwives in India, she still delivers good obstetrician care and can bringing good health of mother and child. can decrease ratio of LSCS. looking for many established centers/clinics/hospitals/birthing centers which runs by midwives independently in India
Preparation for delivery of mother, baby and midwife and equipmentsDR MUKESH SAH
In addition to their delivery bags, midwives “carry” many other invaluable tools ... family planning, delivery preparation, postnatal counseling and breastfeeding. ... With this equipment, we can recover 80% of newborns. ... “Midwifery feels good when both the mother and baby come out of the labor ward alive.
Angina pectoris is a syndrome characterized by sudden severe pressing substernal chest pain or heaviness radiating to the neck, jaw, back and arms.
Those drugs used to prevent, abort or terminate angina are anti angina drugs.
· IndicationsSee Pronunciation· Used systemically and locally .docxodiliagilby
· Indications
See Pronunciation
· Used systemically and locally in a wide variety of chronic diseases including:
· Inflammatory,
· Allergic,
· Hematologic,
· Endocrine,
· Neoplastic,
· Dermatologic,
· Autoimmune disorders,
· Management of cerebral edema,
· Diagnostic agent in adrenal disorders.
Unlabeled Use:
· Short-term administration to high-risk mothers before delivery to prevent respiratory distress syndrome in the newborn.
· Adjunctive management of nausea and vomiting from chemotherapy.
· Treatment of airway edema prior to extubation.
· Used in neonates with bronchopulmonary dysplasia to facilitate ventilator weaning.
Action
· In pharmacologic doses, suppresses inflammation and the normal immune response.
· Has numerous intense metabolic effects (see Adverse Reactions and Side Effects).
· Suppresses adrenal function at chronic doses of 0.75 mg/day.
· Has negligible mineralocorticoid activity.
Therapeutic Effects:
· Suppression of inflammation and modification of the normal immune response.
Pharmacokinetics
Absorption: Well absorbed after oral administration. Sodium phosphate salt is rapidly absorbed after IM administration. Absorption from local sites (intra-articular, intralesional) is slow but complete.
Distribution: Widely distributed, crosses the placenta, and appears to enter breast milk.
Metabolism/Excretion: Mostly metabolized by the liver.
Half-life: Low birth weight infants with BPD: 9.3 hr; Children 3 mo–16 yr: 4.3 hr; Adults: 3–4.5 hr (plasma), 36–54 hr (tissue); adrenal suppression lasts 2.75 days.
Contraind./Precautions
Contraindicated in:
· Active untreated infections (may be used in patients being treated for tuberculous meningitis)
· Known alcohol or bisulfite hypersensitivity or intolerance (some products contain these and should be avoided in susceptible patients)
· Epidural use (may result in serious neurological injury or death)
· Lactation: Avoid chronic use.
Use Cautiously in:
· Chronic treatment (will lead to adrenal suppression; use lowest possible dose for shortest period of time)
· Stress (surgery, infections); supplemental doses may be needed
· Potential infections (may mask signs)
· OB: Safety not established
· Pedi: Early postnatal administration of high doses can cause significant and persistent reductions in neuromotor and cognitive functioning; results in growth; use lowest possible dose for shortest period of time.
Adv. Reactions/Side Effects
Adverse reactions/side effects are much more common with high-dose/long-term therapy
CNS: depression, euphoria, hallucinations, headache, intracranial pressure (children only), insomnia, personality changes, psychoses, restlessness.
EENT: cataracts, intraocular pressure.
CV: hypertension, edema.
GI: PEPTIC ULCERATION, anorexia, nausea, appetite, vomiting.
Derm: acne, wound healing, ecchymoses, hirsutism, petechiae.
Endo: adrenal suppression, hyperglycemia.
F and E: amenorrhea, hypokalemia, alkalosis.
Hemat: THROMBOEMBOLISM, thrombophlebitis.
Metab: weight ga ...
o Information can be used by those who need updated and good quality knowledge about medicine.
o Healthcare providers, such as doctors, pharmacists or nurses and allied health care professionals to help them prescribe ,dispense and administer medicines safely.
o Patients or their care givers, Researchers and general public.
YouTube link: https://youtu.be/gjLi0cwzFz4
Lactation management is the science and art of assisting women and infants with breastfeeding, because the mother-infant pair is dynamically interrelated for breastfeeding, it is imperative to consider both individuals when attempting to assess and “manage” breastfeeding.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
2. A sound understanding of the principle of
safe medication management is essential for
all nurses, midwifes and health agencies
involved in the care of patient, residents and
clients.
A standing order is a document containing
orders for the conduct of routine therapies,
monitoring guidelines, and/or diagnostic
procedure for specific client with identified
clinical problem
3. Standing Orders are
orders in which the nurse
may act to carry out
specific orders for a
patient who presents with
symptoms or needs
addressed in the standing
orders. They must be in
written form and signed
and dated by the Licensed
Independent Practitioner.
4. Examples of situations in which standing orders
may be utilized can include,
◦ Administration of immunizations (e.g. influenza,
pneumococcal, and other vaccines)
◦ Nursing treatment of common health problems
◦ Health screening activities
◦ Occupational health services
◦ Public health clinical services
◦ Telephone triage and advice services
◦ Orders for lab tests.
◦ School health
◦ During labor.
5. To maintain the continuity of
the treatment of the patient.
To protect the life of the
patient.
To create feeling of
responsibility In the members
of health team
6. Providing treatment during emergency
Enhance the quality and activity of health
service.
Developing the feeling of confidence and
responsibility in nurses and other health
workers.
Protecting the general public from troubles.
Enhancing the faith of general public in
medical institution.
7. All IV and controlled drug must be checked by two
midwives.
ANALGESIA- Paracetamol 1gram as a single dose,
once only
ANTACID-Maalox suspension 10ml as a single dose
once only
or
Peptac liquid 10-20ml as a single dose
once only
LAXATIVE- Ispaghula Husk 3.5g one sachet in water
once only
8. IN ELECTIVE LSCS theatre. Sodium Citrate
0.3mg 30ml orally once only immediately
prior to transfer to Theatre
I.V. THERAPY Compound Sodium Lactate 1
litre i.v. over 8-12 hours, to a maximum of
two liters
Heparin 10IU/ml 5ml instilled into i.v.
cannula When required every 4-8 hours
9. LOCAL ANAESTHETIC-Lignocaine 1% 0.1ml intradermally prior to
cannulation once only or Amethocaine gel 4% 1g 45 minutes prior to
venous cannulation once only
NIGHT SEDATION -Temazepam 10mg as a single dose up to 2.00am
in the morning.
DINOPROSTONE VAGINAL GEL-As per induction of labor guidelines.
FOLIC ACID -Folic acid 400microgram tablet once daily, until 12-14
weeks gestation.
DEMULCENT COUGH-Simple linctus 5ml once only PREPARATION
ANTISPASMODIC-Peppermint water 10ml in plenty of water, once only.
10. ANTI –D IMMUNOGLOBULIN
Anti-D immunoglobulin may be given to all
non-sensitized Rh D negative women within 72 hours
of a sensitizing event in the following circumstances
Prior to 20 weeks gestation Anti-D 250iu by I.M.
injection. The following conditions are:
Threatened miscarriage after 12 weeks gestation
Spontaneous miscarriage after 12 weeks gestation
Ectopic pregnancy
Therapeutic termination of pregnancy – medical and
surgical
Following sensitizing events such as amniocentesis
11. After 20 weeks gestation Anti- D 500i.u. by I.M.
injection
Ante partum hemorrhage
External cephalic version
Intrauterine death
Invasive prenatal diagnostic and intrauterine
procedures
Blunt abdominal trauma
Routine Ante-natal Anti-D prophylaxis
Anti-D 500i.u. by I.M. injection at 28 and 34
weeks gestation
12. ANALGESIA -Entonox inhalation as
required
ANTI-EMETICS-Cyclizine 50mg I.M. every 8
hours as required to a maximum of
150mg/24 hours
or
Metoclopramide 10mg I.M.
every 8 hours as required to a maximum of
30mg in 24 hours or 500 micrograms per Kg
in 24 hours for women<60kg
13. ACTIVE MANAGEMENT-Oxytocin 10 i.u.as per
unit policy OF LABOUR
or
Syntometrine 1ml I.M. with
anterior shoulder at delivery
I.V. THERAPY -Compound Sodium Lactate 1
litre I.V. over 8-12 hours as required to a
maximum of 2 litres
Heparin 10u/ml 5ml instilled into
I.V. cannula every 4-8 hours when required
14. LOCAL ANAESTHETIC-Lignocaine 1% 0.1ml
intradermally prior to cannulation, once only
Amethocaine gel 4% 1g prior to
cannulation once only
LAXATIVES-Glycerine Suppository 1 or 2 per
rectum
or
Docusate sodium 90mg micro
enema as required
15. EPISIOTOMY-Lignocaine 1% 10ml by
perineal infiltration.
PAEDIATRICS
The following may be administered to
babies after delivery without reference
to Paediatric staff:
Oxygen by facemask
Phytomenadione 1mg by I.M. injection
16. EPISIOTOMY REPAIR -
Lignocaine 1% by perineal
infiltration to a maximum of 20ml
ANALGESIA -Only one NSAID
should be prescribed at any one
time
17. Caesarean Section for first 24 hours:
Anaesthetist will be responsible for
analgesia. Unless contra-indicated
diclofenac suppository 100mg will be given
rectally in Theatre. One dose of an NSAID
can be given 14-16 hours after the
suppository. If Diclofenac is given, the total
dose must not exceed 150mg by all routes
in any 24 hours period.
18. Vaginal delivery or Cesarean Section after
first 24 hours:
Ibuprofen tablet or syrup 400mg or 600mg
three times a day.
Diclofenac tablet or suppository 50mg three
times a day (to a maximum of 150mg in 24
hours by any route).
19. PARACETAMOL -Only one paracetamol based
analgesic should be prescribed at any one
time.
Paracetamol 1gram every 4-6 hours to a
maximum of 4grams in any 24 hours as plain
or effervescent tablets or rectally as
suppository.
20. ANTIEMETIC- Cyclizine 50mg I.M. every 8 hours as
required to a maximum of 150mg/24 hours.
Metoclopramide 10mg I.M. every 8
hours as required to a maximum of 30mg in 24 hours
or 500 micrograms per Kg in 24 hours for
women<60kg
LAXATIVES-Ispaghula Husk 3.5g, 1 sachet in water
twice daily
Lacunose 10ml orally twice daily
Glycerine suppository 1 or 2 per
rectum as required
21. HAEMORRHOID-Anusol cream apply twice daily
and after each preparations bowel movement
Scheriproct ointment apply twice
daily for 5-7 days then once daily until
symptoms cleared
I.V. THERAPY Compound Sodium Lactate 1 litre
I.V. every 8-12 hours as required to a maximum
of 2 litres
Heparin 10u/ml 5ml instilled into I.V. cannula
every 4-8 hours when required
22. LOCAL ANAESTHETIC-Lignocaine 1% 0.1ml
intradermally prior to cannulation, once only
Amethocaine gel 4% 1g
prior to venous cannulation once only
ANTI –D -Anti-D Immunoglobulin 500i.u or
more. by I.M. injection to Rh D negative women
with a Rh D positive baby within 72 hours of
delivery as per obstetric unit guidelines.
VACCINES -Rubella vaccine (live) 0.5ml by
deep subcutaneous or intramuscular injection if
mother not immune.
23. IRON SUPPLEMENT -Ferrous sulphate tablet
200mg three times a day if haemoglobin
below 10g/dl.
DEMULCENT COUGH-Simple linctus 5ml 3-4
times a day preparation
ANTISPASMODIC -Peppermint water 10ml
in plenty of water once only.